{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:40:47Z","timestamp":1790228447222,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.crad.2026.107259","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T15:52:29Z","timestamp":1769010749000},"page":"107259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Sarcopenia, myosteatosis, and skeletal muscle loss as predictors of poor prognosis in hepatocellular carcinoma patients undergoing intra-arterial therapies"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8277-5384","authenticated-orcid":false,"given":"Y.","family":"Ozbay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9887-4018","authenticated-orcid":false,"given":"F.G.","family":"Eldem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Cay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2016-2624","authenticated-orcid":false,"given":"M.F.","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1488-6012","authenticated-orcid":false,"given":"B.V.","family":"Salanc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0628-7694","authenticated-orcid":false,"given":"A.","family":"Ormanc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4325-847X","authenticated-orcid":false,"given":"U.","family":"Aydingoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Dizdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Peynircioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.crad.2026.107259_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.crad.2026.107259_bib2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.crad.2026.107259_bib3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.crad.2026.107259_bib4","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jhep.2015.02.010","article-title":"Transarterial chemoembolization: modalities, indication, and patient selection","volume":"62","author":"Sieghart","year":"2015","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.crad.2026.107259_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/hep.28453","article-title":"Lipiodol transarterial chemoembolization for hepatocellular carcinoma: a systematic review of efficacy and safety data","volume":"64","author":"Lencioni","year":"2016","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.crad.2026.107259_bib6","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1200\/JCO.2001.19.9.2381","article-title":"Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy","volume":"19","author":"Demark-Wahnefried","year":"2001","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.crad.2026.107259_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/nu13030761","article-title":"Sarcopenia, malnutrition, and cachexia: adapting definitions and terminology of nutritional disorders in older people with cancer","volume":"13","author":"Meza-Valderrama","year":"2021","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.crad.2026.107259_bib8","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s10147-024-02512-4","article-title":"Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy","volume":"29","author":"Sahin","year":"2024","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"10.1016\/j.crad.2026.107259_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4274\/dir.2023.221986","article-title":"Long-term results of liver thermal ablation in patients with hepatocellular carcinoma and colorectal cancer liver metastasis regarding spatial features and tumor-specific variables","volume":"30","author":"Akhan","year":"2024","journal-title":"Diagn Interv Radiol"},{"issue":"10","key":"10.1016\/j.crad.2026.107259_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11101503","article-title":"Sarcopenia is a negative prognostic factor in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies","volume":"11","author":"Loosen","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.crad.2026.107259_bib11","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1186\/s12885-018-4673-2","article-title":"Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies","volume":"18","author":"Kobayashi","year":"2018","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.crad.2026.107259_bib12","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/hepr.13331","article-title":"Skeletal muscle volume loss during transarterial chemoembolization predicts poor prognosis in patients with hepatocellular carcinoma","volume":"49","author":"Fujita","year":"2019","journal-title":"Hepatol Res"},{"issue":"12","key":"10.1016\/j.crad.2026.107259_bib13","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1007\/s11605-013-2348-5","article-title":"Impact of sarcopenia on outcomes following intra-arterial therapy of hepatic malignancies","volume":"17","author":"Dodson","year":"2013","journal-title":"J Gastrointest Surg"},{"issue":"36","key":"10.1016\/j.crad.2026.107259_bib14","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.3748\/wjg.v28.i36.5324","article-title":"Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (Chemo)-embolization","volume":"28","author":"Roth","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.crad.2026.107259_bib15","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.crad.2026.107259_bib16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00384-011-1333-2","article-title":"Impact of fat obesity on laparoscopic total mesorectal excision: more reliable indicator than body mass index","volume":"27","author":"Kang","year":"2012","journal-title":"Int J Colorectal Dis"},{"issue":"3","key":"10.1016\/j.crad.2026.107259_bib17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00384-013-1803-9","article-title":"The impact of visceral obesity on surgical outcomes of laparoscopic surgery for colon cancer","volume":"29","author":"Watanabe","year":"2014","journal-title":"Int J Colorectal Dis"},{"issue":"3","key":"10.1016\/j.crad.2026.107259_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030720","article-title":"The role of sarcopenia and myosteatosis in Short- and long-term outcomes following curative-intent surgery for hepatocellular carcinoma in a European cohort","volume":"14","author":"Meister","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.crad.2026.107259_bib19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/ajt.15577","article-title":"Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation","volume":"20","author":"Czigany","year":"2020","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.crad.2026.107259_bib20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/jcsm.12039","article-title":"Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis","volume":"7","author":"Montano-Loza","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.crad.2026.107259_bib21","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.surg.2016.09.038","article-title":"A clinically applicable muscular index predicts long-term survival in resectable pancreatic cancer","volume":"161","author":"Delitto","year":"2017","journal-title":"Surgery"},{"issue":"11","key":"10.1016\/j.crad.2026.107259_bib22","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/bjs.9258","article-title":"Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma","volume":"100","author":"Harimoto","year":"2013","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.crad.2026.107259_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jhep.2015.02.031","article-title":"Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma","volume":"63","author":"Fujiwara","year":"2015","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.crad.2026.107259_bib24","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11605-015-2838-8","article-title":"Effect of intramuscular adipose tissue content on prognosis in patients undergoing hepatocellular carcinoma resection","volume":"19","author":"Kaibori","year":"2015","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.crad.2026.107259_bib25","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1038\/s41598-023-31184-9","article-title":"Association of myosteatosis with treatment response and survival in patients with hepatocellular carcinoma undergoing chemoembolization: a retrospective cohort study","volume":"13","author":"Bannangkoon","year":"2023","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.crad.2026.107259_bib26","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00330-022-08980-4","article-title":"Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma","volume":"33","author":"Chen","year":"2023","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.crad.2026.107259_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12010262","article-title":"Myosteatosis is not associated with complications or survival in HCC patients undergoing trans arterial embolization","volume":"12","author":"Masetti","year":"2022","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.crad.2026.107259_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2024.101125","article-title":"AI-derived body composition parameters as prognostic factors in patients with HCC undergoing TACE in a multicenter study","volume":"6","author":"M\u00fcller","year":"2024","journal-title":"JHEP Reports"},{"key":"10.1016\/j.crad.2026.107259_bib29","first-page":"1","article-title":"Prognostic value of the body composition parameters in patients with colorectal liver metastases undergoing intra-arterial treatment","author":"Ozbay","year":"2025","journal-title":"Expert Rev Anticancer Ther"},{"issue":"3","key":"10.1016\/j.crad.2026.107259_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e25237","article-title":"Impact of body composition on the prognosis of hepatocellular carcinoma patients treated with transarterial chemoembolization: a systematic review and meta-analysis","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926026000358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926026000358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:35:44Z","timestamp":1773970544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926026000358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":30,"alternative-id":["S0009926026000358"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2026.107259","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sarcopenia, myosteatosis, and skeletal muscle loss as predictors of poor prognosis in hepatocellular carcinoma patients undergoing intra-arterial therapies","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2026.107259","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Royal College of Radiologists. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107259"}}